Forecast & Rating4 analysts currently cover Vistagen Therap, of which 0 give a positive rating. The average price target is $1.00, about 341.7% upside from the current price of $0.23. Coverage is limited, so the data is for reference only. Data as of Jun 30, 2026; this does not constitute investment advice.
Jun 30, 2026
Price forecast
$1.00341.70%
Forecast & RatingHold
4analysts
Strong buy0.00%
Buy0.00%
Hold100.00%
Sell0.00%
Strong sell0.00%
Strong buy
0
Buy
0
Hold
4
Sell
0
Strong sell
0
Target price forecast
Forecast baselineJul 19, 2026
Forecast met0.4%
Stock price$0.23
Average forecast price$1.0
Highest forecast price$1
Lowest forecast price$1
Average forecast price
$1.0
Highest forecast price
$1
Lowest forecast price
$1
Analyst ratings
Strong buy
Buy
Hold
Sell
Strong sell
Source: S&P Global
This information is for reference only and is not investment advice.